Value Bridge — THE QUEENS MEDICAL CENTER
Current $14M → Target $45M (+$31.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$13.8M
Current EBITDA
$45.3M
Target EBITDA
+$31.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$7.1M
Payer Mix Optimization
$17.1M
Cost to Collect Reduction
$5.7M
Clean Claim Improvement
$4.3M
Volume & Rate Growth
$28.5M
What This Means
The 7-lever model projects a 228% EBITDA uplift from $14M to $45M. The highest-impact lever is Volume & Rate Growth at $11.4M probability-weighted.
IC talking point: "We see $31M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $346M in equity value creation."